Factors such as hormone receptor expression, human epidermal growth factor receptor 2 (HER2) amplification, tumor size, the involvement of lymph nodes, and histologic grade have been used to determine whether patients with early breast cancer should be treated with chemotherapy, endocrine therapy, or HER2 directed treatments [2]. The gene discussed is ERBB2; the disease is breast cancer.